| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 62 | 2022 | 981 | 6.810 |
Why?
|
| Status Epilepticus | 32 | 2023 | 444 | 5.700 |
Why?
|
| Critical Care | 59 | 2023 | 2647 | 5.640 |
Why?
|
| Brain Injuries | 38 | 2022 | 2025 | 5.470 |
Why?
|
| Critical Illness | 44 | 2022 | 2670 | 3.600 |
Why?
|
| Intracranial Pressure | 17 | 2022 | 326 | 3.470 |
Why?
|
| Brain Death | 8 | 2023 | 348 | 3.270 |
Why?
|
| Apnea | 6 | 2020 | 195 | 2.420 |
Why?
|
| Intracranial Hypertension | 16 | 2022 | 186 | 2.370 |
Why?
|
| Anticonvulsants | 24 | 2023 | 1916 | 2.130 |
Why?
|
| Child | 197 | 2023 | 77709 | 2.100 |
Why?
|
| Shock, Septic | 14 | 2020 | 775 | 2.050 |
Why?
|
| Craniosynostoses | 11 | 2022 | 401 | 1.950 |
Why?
|
| Midazolam | 8 | 2022 | 270 | 1.910 |
Why?
|
| Respiration, Artificial | 27 | 2021 | 2569 | 1.850 |
Why?
|
| Pediatrics | 24 | 2020 | 3475 | 1.690 |
Why?
|
| Multiple Organ Failure | 10 | 2022 | 390 | 1.690 |
Why?
|
| Diabetic Ketoacidosis | 7 | 2020 | 245 | 1.670 |
Why?
|
| Cerebrovascular Circulation | 18 | 2020 | 2731 | 1.660 |
Why?
|
| Hypothermia, Induced | 9 | 2019 | 752 | 1.600 |
Why?
|
| Sepsis | 17 | 2022 | 2593 | 1.580 |
Why?
|
| Writing | 2 | 2023 | 206 | 1.460 |
Why?
|
| Coma | 11 | 2020 | 475 | 1.420 |
Why?
|
| Hypoglycemia | 8 | 2014 | 861 | 1.390 |
Why?
|
| Child, Preschool | 119 | 2021 | 41006 | 1.390 |
Why?
|
| Delirium | 6 | 2020 | 1609 | 1.340 |
Why?
|
| Hyperglycemia | 12 | 2014 | 1373 | 1.320 |
Why?
|
| Infant | 114 | 2022 | 35136 | 1.280 |
Why?
|
| Monitoring, Physiologic | 19 | 2021 | 1738 | 1.260 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2020 | 113 | 1.150 |
Why?
|
| Seizures | 17 | 2023 | 2859 | 1.140 |
Why?
|
| Humans | 315 | 2023 | 744343 | 1.050 |
Why?
|
| Brain Diseases | 7 | 2022 | 1563 | 1.050 |
Why?
|
| Glasgow Coma Scale | 13 | 2022 | 570 | 1.050 |
Why?
|
| Brain Edema | 6 | 2014 | 617 | 1.010 |
Why?
|
| Respiratory Insufficiency | 13 | 2022 | 1199 | 0.950 |
Why?
|
| Blood Glucose | 11 | 2014 | 6256 | 0.950 |
Why?
|
| Hypnotics and Sedatives | 4 | 2018 | 1162 | 0.920 |
Why?
|
| Hydrocortisone | 5 | 2015 | 1826 | 0.910 |
Why?
|
| Heart Arrest | 7 | 2017 | 1470 | 0.900 |
Why?
|
| Pentobarbital | 3 | 2022 | 155 | 0.890 |
Why?
|
| Infant, Newborn | 59 | 2020 | 25625 | 0.850 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2020 | 1354 | 0.840 |
Why?
|
| Diagnostic Techniques, Neurological | 2 | 2020 | 63 | 0.840 |
Why?
|
| Cholinergic Antagonists | 3 | 2021 | 165 | 0.830 |
Why?
|
| High-Frequency Ventilation | 5 | 2008 | 87 | 0.820 |
Why?
|
| Neurology | 6 | 2023 | 763 | 0.820 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 133 | 0.800 |
Why?
|
| Brain | 16 | 2022 | 26385 | 0.780 |
Why?
|
| Brain Concussion | 3 | 2019 | 1320 | 0.780 |
Why?
|
| Epinephrine | 2 | 2015 | 792 | 0.770 |
Why?
|
| Cholinesterases | 1 | 2020 | 34 | 0.750 |
Why?
|
| Central Nervous System Diseases | 5 | 2020 | 518 | 0.750 |
Why?
|
| Benzodiazepines | 9 | 2023 | 1101 | 0.750 |
Why?
|
| Paralysis | 1 | 2022 | 247 | 0.740 |
Why?
|
| Electroencephalography | 19 | 2022 | 6150 | 0.740 |
Why?
|
| Unconsciousness | 2 | 2020 | 263 | 0.740 |
Why?
|
| Catastrophic Illness | 1 | 2020 | 57 | 0.740 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2008 | 329 | 0.730 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2017 | 980 | 0.730 |
Why?
|
| Hospital Mortality | 14 | 2022 | 5317 | 0.720 |
Why?
|
| Adolescent | 89 | 2022 | 85781 | 0.710 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2020 | 292 | 0.710 |
Why?
|
| Clinical Protocols | 7 | 2022 | 1462 | 0.710 |
Why?
|
| Craniocerebral Trauma | 6 | 2006 | 482 | 0.690 |
Why?
|
| Shock | 2 | 2015 | 318 | 0.670 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 200 | 0.670 |
Why?
|
| Nervous System Diseases | 4 | 2022 | 1622 | 0.660 |
Why?
|
| Bioethical Issues | 1 | 2020 | 124 | 0.660 |
Why?
|
| Anesthesia, General | 3 | 2017 | 1171 | 0.660 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 1423 | 0.640 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 214 | 0.640 |
Why?
|
| Carbon Dioxide | 7 | 2020 | 1150 | 0.640 |
Why?
|
| Polyneuropathies | 1 | 2019 | 137 | 0.630 |
Why?
|
| Fluid Therapy | 9 | 2020 | 593 | 0.630 |
Why?
|
| Barbiturates | 4 | 2019 | 114 | 0.630 |
Why?
|
| Decompressive Craniectomy | 4 | 2020 | 72 | 0.620 |
Why?
|
| Patient Selection | 6 | 2019 | 4215 | 0.610 |
Why?
|
| Hyperoxia | 1 | 2020 | 262 | 0.610 |
Why?
|
| Research Report | 1 | 2021 | 355 | 0.610 |
Why?
|
| Somatotrophs | 1 | 2017 | 2 | 0.600 |
Why?
|
| S100 Proteins | 2 | 2009 | 259 | 0.600 |
Why?
|
| Bronchiolitis, Viral | 2 | 2008 | 74 | 0.590 |
Why?
|
| Consciousness Disorders | 2 | 2020 | 418 | 0.580 |
Why?
|
| Off-Label Use | 1 | 2018 | 169 | 0.570 |
Why?
|
| Hypopituitarism | 3 | 2007 | 254 | 0.570 |
Why?
|
| Oxygen | 10 | 2020 | 4189 | 0.570 |
Why?
|
| Trauma Severity Indices | 3 | 2014 | 481 | 0.570 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 565 | 0.570 |
Why?
|
| Cerebral Veins | 1 | 2018 | 156 | 0.570 |
Why?
|
| Drowning | 1 | 2016 | 27 | 0.570 |
Why?
|
| Glucose Clamp Technique | 1 | 2017 | 266 | 0.560 |
Why?
|
| Headache Disorders | 1 | 2018 | 130 | 0.560 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 168 | 0.550 |
Why?
|
| Practice Guidelines as Topic | 17 | 2020 | 7279 | 0.550 |
Why?
|
| Diazepam | 3 | 2023 | 205 | 0.550 |
Why?
|
| Intensive Care, Neonatal | 6 | 2018 | 198 | 0.540 |
Why?
|
| Neuroprotective Agents | 3 | 2016 | 941 | 0.530 |
Why?
|
| Male | 121 | 2021 | 350118 | 0.520 |
Why?
|
| Head | 3 | 2017 | 880 | 0.510 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 231 | 0.510 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 574 | 0.510 |
Why?
|
| Ischemic Attack, Transient | 3 | 2015 | 935 | 0.500 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2015 | 177 | 0.500 |
Why?
|
| Bronchiolitis | 3 | 2013 | 458 | 0.500 |
Why?
|
| Movement Disorders | 2 | 2017 | 445 | 0.490 |
Why?
|
| Female | 114 | 2021 | 380194 | 0.480 |
Why?
|
| Homeostasis | 5 | 2019 | 3340 | 0.480 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 687 | 0.480 |
Why?
|
| Disclosure | 1 | 2020 | 736 | 0.470 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 56 | 0.470 |
Why?
|
| Cerebral Cortex | 6 | 2021 | 5708 | 0.470 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.470 |
Why?
|
| Informed Consent | 2 | 2017 | 995 | 0.470 |
Why?
|
| Sodium Chloride | 3 | 2013 | 625 | 0.470 |
Why?
|
| Hypoglycemic Agents | 6 | 2017 | 2872 | 0.470 |
Why?
|
| England | 11 | 2014 | 522 | 0.460 |
Why?
|
| Neurosurgery | 2 | 2019 | 643 | 0.460 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 110 | 0.460 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 302 | 0.450 |
Why?
|
| Mannitol | 1 | 2014 | 181 | 0.450 |
Why?
|
| Hemodynamics | 8 | 2020 | 4199 | 0.450 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 896 | 0.450 |
Why?
|
| Patient Positioning | 1 | 2016 | 324 | 0.450 |
Why?
|
| Child Development | 2 | 2016 | 2223 | 0.440 |
Why?
|
| Intubation, Intratracheal | 5 | 2013 | 1364 | 0.440 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 987 | 0.440 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2013 | 57 | 0.440 |
Why?
|
| Brain Damage, Chronic | 3 | 2005 | 265 | 0.440 |
Why?
|
| Insulin | 9 | 2017 | 6580 | 0.440 |
Why?
|
| Intensive Care Units | 11 | 2022 | 3679 | 0.440 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 238 | 0.430 |
Why?
|
| Hydrodynamics | 1 | 2013 | 158 | 0.430 |
Why?
|
| Bayes Theorem | 3 | 2019 | 2309 | 0.420 |
Why?
|
| Patient Discharge | 3 | 2019 | 3313 | 0.420 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 632 | 0.420 |
Why?
|
| Drug Utilization | 1 | 2018 | 1183 | 0.420 |
Why?
|
| Coronary Care Units | 1 | 2013 | 214 | 0.420 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 671 | 0.420 |
Why?
|
| Glycemic Index | 3 | 2011 | 395 | 0.410 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 1011 | 0.410 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2009 | 135 | 0.410 |
Why?
|
| Health Status Indicators | 1 | 2017 | 969 | 0.400 |
Why?
|
| Brain Ischemia | 7 | 2015 | 3265 | 0.400 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 2274 | 0.390 |
Why?
|
| Hypovolemia | 3 | 2006 | 45 | 0.390 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 417 | 0.390 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 248 | 0.390 |
Why?
|
| Attitude | 1 | 2016 | 776 | 0.380 |
Why?
|
| Neuroimmunomodulation | 3 | 2018 | 157 | 0.380 |
Why?
|
| Vasoconstrictor Agents | 5 | 2020 | 642 | 0.380 |
Why?
|
| Stroke | 5 | 2020 | 9981 | 0.380 |
Why?
|
| Models, Biological | 4 | 2018 | 9583 | 0.380 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2010 | 4 | 0.370 |
Why?
|
| Blood Pressure | 9 | 2019 | 8554 | 0.370 |
Why?
|
| Body Temperature | 1 | 2013 | 777 | 0.370 |
Why?
|
| Croup | 2 | 2003 | 23 | 0.370 |
Why?
|
| Hypotension | 3 | 2014 | 884 | 0.360 |
Why?
|
| Organ Transplantation | 1 | 2020 | 1139 | 0.360 |
Why?
|
| Nitric Oxide | 9 | 2002 | 2132 | 0.360 |
Why?
|
| Perfusion | 1 | 2014 | 1360 | 0.360 |
Why?
|
| Severity of Illness Index | 14 | 2022 | 15540 | 0.350 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 36 | 0.350 |
Why?
|
| Enteral Nutrition | 3 | 2021 | 763 | 0.340 |
Why?
|
| Mountaineering | 1 | 2009 | 45 | 0.340 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1261 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2022 | 9959 | 0.330 |
Why?
|
| Infant, Premature | 3 | 2016 | 2044 | 0.320 |
Why?
|
| Prosencephalon | 1 | 2010 | 303 | 0.320 |
Why?
|
| Epilepsy | 3 | 2021 | 3310 | 0.320 |
Why?
|
| Hyperventilation | 3 | 2005 | 81 | 0.320 |
Why?
|
| Resuscitation | 4 | 2020 | 658 | 0.320 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1889 | 0.320 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 216 | 0.310 |
Why?
|
| Prospective Studies | 34 | 2021 | 53288 | 0.310 |
Why?
|
| Altitude | 1 | 2009 | 161 | 0.310 |
Why?
|
| Corpus Callosum | 2 | 2022 | 737 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2012 | 4043 | 0.300 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 475 | 0.300 |
Why?
|
| Intelligence | 1 | 2012 | 920 | 0.300 |
Why?
|
| Posture | 1 | 2012 | 958 | 0.300 |
Why?
|
| Meningitis, Meningococcal | 1 | 2007 | 43 | 0.300 |
Why?
|
| Hippocampus | 7 | 2006 | 3675 | 0.300 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 957 | 0.300 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 339 | 0.290 |
Why?
|
| Positive-Pressure Respiration | 4 | 1999 | 633 | 0.290 |
Why?
|
| Biomedical Research | 3 | 2020 | 3309 | 0.290 |
Why?
|
| Patient Transfer | 4 | 2010 | 761 | 0.290 |
Why?
|
| Models, Statistical | 3 | 2017 | 5102 | 0.280 |
Why?
|
| Perioperative Care | 1 | 2014 | 1002 | 0.280 |
Why?
|
| Hospitals | 2 | 2020 | 3952 | 0.270 |
Why?
|
| Migraine Disorders | 1 | 2018 | 1620 | 0.270 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2008 | 274 | 0.270 |
Why?
|
| Pulmonary Gas Exchange | 5 | 2014 | 382 | 0.270 |
Why?
|
| Retinal Hemorrhage | 2 | 2004 | 96 | 0.270 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1403 | 0.270 |
Why?
|
| Encephalocele | 2 | 2020 | 136 | 0.270 |
Why?
|
| Diffuse Axonal Injury | 1 | 2006 | 49 | 0.270 |
Why?
|
| Hypothalamic Diseases | 1 | 2007 | 135 | 0.270 |
Why?
|
| Hematoma, Subdural | 2 | 2004 | 126 | 0.270 |
Why?
|
| Acrocephalosyndactylia | 2 | 2021 | 89 | 0.270 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2899 | 0.260 |
Why?
|
| Retrospective Studies | 34 | 2023 | 77449 | 0.260 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2021 | 546 | 0.260 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 184 | 0.260 |
Why?
|
| Lymphopenia | 2 | 2004 | 285 | 0.260 |
Why?
|
| Ambulances | 1 | 2005 | 95 | 0.260 |
Why?
|
| Child Mortality | 2 | 2014 | 198 | 0.260 |
Why?
|
| Length of Stay | 9 | 2020 | 6309 | 0.250 |
Why?
|
| Ferritins | 1 | 2007 | 590 | 0.250 |
Why?
|
| Encephalitis | 2 | 2018 | 423 | 0.250 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3843 | 0.250 |
Why?
|
| Death | 3 | 2020 | 678 | 0.250 |
Why?
|
| Phenotype | 3 | 2022 | 16365 | 0.240 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2003 | 8 | 0.240 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 1999 | 80 | 0.230 |
Why?
|
| Pulmonary Medicine | 1 | 2006 | 213 | 0.230 |
Why?
|
| Anesthesiology | 1 | 2014 | 1060 | 0.230 |
Why?
|
| Battered Child Syndrome | 1 | 2003 | 11 | 0.230 |
Why?
|
| Wales | 4 | 2010 | 85 | 0.220 |
Why?
|
| Hemostasis | 1 | 2006 | 458 | 0.220 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1405 | 0.220 |
Why?
|
| Isotonic Solutions | 4 | 2006 | 119 | 0.220 |
Why?
|
| Treatment Outcome | 27 | 2021 | 63114 | 0.220 |
Why?
|
| Hemoglobins | 1 | 2009 | 1534 | 0.220 |
Why?
|
| Growth Hormone | 1 | 2005 | 705 | 0.220 |
Why?
|
| Acute Disease | 11 | 2017 | 7149 | 0.220 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2004 | 120 | 0.220 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 1995 | 249 | 0.220 |
Why?
|
| Hematology | 1 | 2006 | 221 | 0.220 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3610 | 0.220 |
Why?
|
| Prolactin | 1 | 2004 | 669 | 0.210 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1154 | 0.210 |
Why?
|
| Hospitalization | 12 | 2018 | 10262 | 0.210 |
Why?
|
| Skull | 2 | 2005 | 813 | 0.210 |
Why?
|
| Life Support Care | 2 | 2011 | 228 | 0.210 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1504 | 0.210 |
Why?
|
| Cohort Studies | 12 | 2021 | 40561 | 0.210 |
Why?
|
| Time Factors | 22 | 2021 | 40075 | 0.200 |
Why?
|
| Masks | 1 | 2003 | 197 | 0.200 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2002 | 101 | 0.200 |
Why?
|
| Papilledema | 2 | 2016 | 118 | 0.190 |
Why?
|
| Peer Review | 1 | 2023 | 209 | 0.190 |
Why?
|
| Pilot Projects | 4 | 2018 | 8324 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 2 | 2017 | 570 | 0.190 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2001 | 110 | 0.190 |
Why?
|
| Consensus | 5 | 2020 | 2959 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 612 | 0.190 |
Why?
|
| Emergency Treatment | 2 | 2018 | 517 | 0.180 |
Why?
|
| Recovery of Function | 1 | 2010 | 2925 | 0.180 |
Why?
|
| Seizures, Febrile | 1 | 2021 | 111 | 0.180 |
Why?
|
| Research Design | 7 | 2022 | 5987 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 957 | 0.180 |
Why?
|
| Respiration Disorders | 2 | 2004 | 371 | 0.170 |
Why?
|
| Hospitals, Pediatric | 6 | 2020 | 1775 | 0.170 |
Why?
|
| Withholding Treatment | 2 | 2011 | 599 | 0.170 |
Why?
|
| Albumins | 1 | 2002 | 569 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2018 | 2886 | 0.170 |
Why?
|
| Dantrolene | 1 | 1998 | 26 | 0.170 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 7659 | 0.170 |
Why?
|
| Serum Albumin | 1 | 2002 | 676 | 0.170 |
Why?
|
| United States | 11 | 2020 | 69872 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3086 | 0.160 |
Why?
|
| Animals, Newborn | 3 | 2016 | 2726 | 0.160 |
Why?
|
| Photoperiod | 1 | 2019 | 136 | 0.160 |
Why?
|
| Bioethics | 1 | 2020 | 116 | 0.160 |
Why?
|
| Achondroplasia | 1 | 1998 | 26 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2010 | 1479 | 0.160 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2018 | 25 | 0.160 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 252 | 0.160 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2018 | 32 | 0.160 |
Why?
|
| Hepatic Encephalopathy | 1 | 2019 | 139 | 0.160 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 163 | 0.160 |
Why?
|
| Respiratory Tract Infections | 2 | 2003 | 961 | 0.160 |
Why?
|
| Acetylcholine | 1 | 2020 | 621 | 0.160 |
Why?
|
| Plasma Substitutes | 3 | 2004 | 57 | 0.160 |
Why?
|
| Hypertonic Solutions | 3 | 2004 | 93 | 0.160 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2015 | 944 | 0.160 |
Why?
|
| Decision Making | 4 | 2018 | 3887 | 0.160 |
Why?
|
| Cytokines | 3 | 2017 | 7322 | 0.160 |
Why?
|
| Neurotoxins | 3 | 1995 | 237 | 0.160 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.160 |
Why?
|
| Liver Failure, Acute | 1 | 2019 | 165 | 0.150 |
Why?
|
| Centralized Hospital Services | 1 | 1997 | 18 | 0.150 |
Why?
|
| Rehydration Solutions | 3 | 2004 | 47 | 0.150 |
Why?
|
| Bed Occupancy | 1 | 1997 | 41 | 0.150 |
Why?
|
| Reperfusion | 1 | 1998 | 284 | 0.150 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 8863 | 0.150 |
Why?
|
| Brain Stem | 2 | 2020 | 846 | 0.150 |
Why?
|
| Moral Development | 1 | 2016 | 13 | 0.150 |
Why?
|
| Emergencies | 3 | 2016 | 1170 | 0.150 |
Why?
|
| Parents | 2 | 2014 | 3407 | 0.150 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14722 | 0.150 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2018 | 302 | 0.150 |
Why?
|
| ROC Curve | 4 | 2014 | 3527 | 0.150 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2001 | 895 | 0.150 |
Why?
|
| Postoperative Complications | 7 | 2014 | 15295 | 0.150 |
Why?
|
| Inflammation | 1 | 2017 | 10638 | 0.150 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 233 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 440 | 0.140 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1855 | 0.140 |
Why?
|
| Young Adult | 12 | 2021 | 56430 | 0.140 |
Why?
|
| Parenteral Nutrition | 2 | 2018 | 650 | 0.140 |
Why?
|
| Prognosis | 14 | 2022 | 29063 | 0.140 |
Why?
|
| Meningitis | 1 | 1998 | 216 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1400 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 123 | 0.140 |
Why?
|
| Leptin | 1 | 2004 | 1599 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2019 | 413 | 0.140 |
Why?
|
| Snoring | 1 | 2017 | 191 | 0.140 |
Why?
|
| Myasthenia Gravis | 1 | 1998 | 199 | 0.140 |
Why?
|
| Dizocilpine Maleate | 2 | 1994 | 176 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 855 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2018 | 262 | 0.130 |
Why?
|
| Supine Position | 1 | 2016 | 205 | 0.130 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1995 | 43 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2016 | 189 | 0.130 |
Why?
|
| Medical Futility | 1 | 1996 | 127 | 0.130 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 426 | 0.130 |
Why?
|
| Lung | 5 | 2016 | 9856 | 0.130 |
Why?
|
| Lidocaine | 1 | 2018 | 544 | 0.130 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1995 | 29 | 0.130 |
Why?
|
| Altitude Sickness | 1 | 2016 | 92 | 0.130 |
Why?
|
| Adult | 21 | 2023 | 214055 | 0.130 |
Why?
|
| Tetrodotoxin | 2 | 1994 | 259 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2012 | 20129 | 0.130 |
Why?
|
| Palliative Care | 2 | 2010 | 3493 | 0.130 |
Why?
|
| Pertussis Vaccine | 1 | 1994 | 34 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2020 | 10943 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 1998 | 531 | 0.130 |
Why?
|
| Language Development Disorders | 1 | 2016 | 196 | 0.130 |
Why?
|
| Neurons | 4 | 2012 | 9338 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 424 | 0.130 |
Why?
|
| Internationality | 1 | 2020 | 1003 | 0.120 |
Why?
|
| Acute Kidney Injury | 3 | 2006 | 1972 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 610 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 7913 | 0.120 |
Why?
|
| Pulmonary Surfactants | 1 | 1995 | 162 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 336 | 0.120 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 547 | 0.120 |
Why?
|
| Bereavement | 2 | 2018 | 277 | 0.120 |
Why?
|
| Cell Enlargement | 1 | 2014 | 61 | 0.120 |
Why?
|
| Abdomen | 1 | 2020 | 1118 | 0.120 |
Why?
|
| Methylprednisolone | 1 | 1996 | 387 | 0.120 |
Why?
|
| Brazil | 2 | 2011 | 1270 | 0.120 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 1813 | 0.120 |
Why?
|
| Neuroblastoma | 1 | 2002 | 1226 | 0.120 |
Why?
|
| Risk Factors | 11 | 2020 | 72290 | 0.120 |
Why?
|
| Logistic Models | 4 | 2008 | 13408 | 0.120 |
Why?
|
| Immunization, Secondary | 2 | 1999 | 340 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1997 | 306 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1995 | 260 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 2557 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 867 | 0.110 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1917 | 0.110 |
Why?
|
| Syndrome | 5 | 2020 | 3251 | 0.110 |
Why?
|
| India | 1 | 2019 | 2197 | 0.110 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2004 | 137 | 0.110 |
Why?
|
| Feedback | 1 | 2017 | 795 | 0.110 |
Why?
|
| Bronchi | 1 | 1997 | 840 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 552 | 0.110 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.110 |
Why?
|
| Hernia, Umbilical | 1 | 1993 | 96 | 0.110 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 2291 | 0.110 |
Why?
|
| Follow-Up Studies | 9 | 2022 | 39050 | 0.100 |
Why?
|
| Neurologic Examination | 3 | 2023 | 930 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 19905 | 0.100 |
Why?
|
| Health Care Costs | 3 | 2014 | 3209 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 512 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12245 | 0.100 |
Why?
|
| Trachea | 2 | 1997 | 1076 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 1420 | 0.100 |
Why?
|
| Medical Errors | 1 | 2000 | 1297 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 35421 | 0.100 |
Why?
|
| Neonatology | 1 | 2013 | 122 | 0.100 |
Why?
|
| Administration, Inhalation | 7 | 2002 | 1105 | 0.100 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 683 | 0.100 |
Why?
|
| Conscious Sedation | 1 | 2016 | 528 | 0.100 |
Why?
|
| Isoflurane | 1 | 2014 | 380 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2020 | 2266 | 0.100 |
Why?
|
| Analgesia | 1 | 2016 | 461 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2016 | 726 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2029 | 0.100 |
Why?
|
| Polysomnography | 4 | 2021 | 1776 | 0.100 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1991 | 35 | 0.100 |
Why?
|
| Nausea | 1 | 2014 | 673 | 0.100 |
Why?
|
| Analysis of Variance | 6 | 2017 | 6365 | 0.100 |
Why?
|
| Ventilator Weaning | 3 | 2010 | 148 | 0.100 |
Why?
|
| Quality of Life | 4 | 2022 | 12804 | 0.090 |
Why?
|
| Hemangioma | 1 | 1996 | 738 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 798 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3341 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 67 | 0.090 |
Why?
|
| Thiopental | 1 | 1989 | 59 | 0.090 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12959 | 0.090 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2014 | 780 | 0.090 |
Why?
|
| Pain | 1 | 2004 | 4986 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2453 | 0.080 |
Why?
|
| Rats | 8 | 2016 | 24260 | 0.080 |
Why?
|
| Anemia | 1 | 2018 | 1506 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 2015 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 500 | 0.080 |
Why?
|
| Argentina | 1 | 2009 | 232 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2007 | 6459 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 426 | 0.080 |
Why?
|
| Pituitary Gland | 2 | 2008 | 665 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 281 | 0.080 |
Why?
|
| Drug Design | 1 | 2013 | 1076 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 3674 | 0.080 |
Why?
|
| Culture Techniques | 3 | 2001 | 554 | 0.080 |
Why?
|
| Craniofacial Dysostosis | 1 | 2008 | 73 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 1017 | 0.080 |
Why?
|
| Analgesics | 1 | 2014 | 1040 | 0.080 |
Why?
|
| Complementary Therapies | 1 | 2011 | 486 | 0.080 |
Why?
|
| Aging | 2 | 2004 | 8664 | 0.080 |
Why?
|
| Spasms, Infantile | 1 | 1991 | 305 | 0.080 |
Why?
|
| Bronchodilator Agents | 2 | 2002 | 502 | 0.080 |
Why?
|
| Phosphocreatine | 2 | 2000 | 269 | 0.070 |
Why?
|
| Respiratory System Agents | 2 | 1997 | 29 | 0.070 |
Why?
|
| Europe | 4 | 2013 | 3339 | 0.070 |
Why?
|
| Radiography | 2 | 2014 | 7023 | 0.070 |
Why?
|
| Shaken Baby Syndrome | 2 | 2004 | 23 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2010 | 594 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 380 | 0.070 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2006 | 20 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1270 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 615 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 2305 | 0.070 |
Why?
|
| Whooping Cough | 2 | 1999 | 82 | 0.070 |
Why?
|
| Heart Rate | 1 | 2017 | 4091 | 0.070 |
Why?
|
| Microcirculation | 1 | 2011 | 1286 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1996 | 2107 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4933 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2161 | 0.070 |
Why?
|
| Bicarbonates | 2 | 2005 | 313 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.070 |
Why?
|
| State Medicine | 1 | 2007 | 217 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2014 | 1471 | 0.070 |
Why?
|
| Ireland | 3 | 2015 | 161 | 0.070 |
Why?
|
| Poverty Areas | 3 | 2018 | 275 | 0.070 |
Why?
|
| Patient Admission | 2 | 2015 | 1380 | 0.070 |
Why?
|
| Diagnosis-Related Groups | 2 | 1998 | 455 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2740 | 0.070 |
Why?
|
| Transportation of Patients | 2 | 2018 | 185 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 1988 | 494 | 0.070 |
Why?
|
| Behavior Therapy | 1 | 2011 | 865 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1519 | 0.070 |
Why?
|
| Hyponatremia | 1 | 2009 | 298 | 0.070 |
Why?
|
| Child Behavior | 1 | 2011 | 839 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2158 | 0.070 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 333 | 0.070 |
Why?
|
| Burnout, Professional | 1 | 2014 | 694 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2017 | 6442 | 0.070 |
Why?
|
| Societies, Medical | 3 | 2023 | 3743 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2007 | 571 | 0.070 |
Why?
|
| Oximetry | 1 | 2009 | 471 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1876 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1025 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1177 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 648 | 0.060 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2004 | 18 | 0.060 |
Why?
|
| Patient Care Team | 4 | 2011 | 2531 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2005 | 138 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 185 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3617 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2118 | 0.060 |
Why?
|
| Sleep | 2 | 2017 | 4623 | 0.060 |
Why?
|
| Risk | 2 | 2007 | 9687 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2006 | 783 | 0.060 |
Why?
|
| N-Methylaspartate | 3 | 1995 | 231 | 0.060 |
Why?
|
| Diffusion | 1 | 2005 | 833 | 0.060 |
Why?
|
| Hormones | 1 | 2007 | 889 | 0.060 |
Why?
|
| Kenya | 2 | 2018 | 685 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 1993 | 1537 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2002 | 683 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1184 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4467 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
| Colloids | 1 | 2002 | 136 | 0.050 |
Why?
|
| Cross Infection | 2 | 2004 | 1416 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 745 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2005 | 3461 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1312 | 0.050 |
Why?
|
| Airway Obstruction | 2 | 1998 | 664 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2006 | 607 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 281 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2012 | 1928 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2005 | 482 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 2025 | 0.050 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2021 | 38 | 0.050 |
Why?
|
| Medical Audit | 3 | 2009 | 467 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 7729 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 123 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5391 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 748 | 0.050 |
Why?
|
| Diuretics, Osmotic | 1 | 2001 | 37 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 578 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5078 | 0.050 |
Why?
|
| Atrophy | 1 | 2006 | 1583 | 0.050 |
Why?
|
| Survival Rate | 5 | 2005 | 12788 | 0.050 |
Why?
|
| Dura Mater | 1 | 2003 | 291 | 0.050 |
Why?
|
| Glutamates | 2 | 1992 | 398 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1774 | 0.050 |
Why?
|
| Energy Intake | 2 | 2021 | 2148 | 0.050 |
Why?
|
| Research | 2 | 2006 | 1999 | 0.050 |
Why?
|
| France | 1 | 2011 | 517 | 0.050 |
Why?
|
| Peer Review, Research | 1 | 2023 | 329 | 0.050 |
Why?
|
| Cadaver | 2 | 2022 | 1337 | 0.040 |
Why?
|
| Syringomyelia | 1 | 2020 | 64 | 0.040 |
Why?
|
| Phenytoin | 1 | 2020 | 197 | 0.040 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 514 | 0.040 |
Why?
|
| Phenobarbital | 1 | 2020 | 193 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6770 | 0.040 |
Why?
|
| Glutamic Acid | 3 | 1995 | 1169 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 696 | 0.040 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 174 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 390 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 1998 | 31 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2004 | 890 | 0.040 |
Why?
|
| Hospice Care | 2 | 2010 | 672 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21746 | 0.040 |
Why?
|
| Algorithms | 5 | 2020 | 13881 | 0.040 |
Why?
|
| Anisotropy | 1 | 2022 | 1265 | 0.040 |
Why?
|
| Pulmonary Heart Disease | 1 | 1998 | 36 | 0.040 |
Why?
|
| Adenoids | 1 | 1998 | 33 | 0.040 |
Why?
|
| Acidosis, Respiratory | 1 | 1998 | 37 | 0.040 |
Why?
|
| Viscera | 1 | 1999 | 139 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2022 | 554 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 242 | 0.040 |
Why?
|
| Peer Group | 1 | 2023 | 635 | 0.040 |
Why?
|
| Prevalence | 4 | 2020 | 15226 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 320 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 631 | 0.040 |
Why?
|
| Convalescence | 1 | 1998 | 105 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 789 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1998 | 193 | 0.040 |
Why?
|
| Victoria | 1 | 1997 | 67 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2000 | 3760 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2737 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1237 | 0.040 |
Why?
|
| Scotland | 1 | 1997 | 155 | 0.040 |
Why?
|
| Apoptosis | 2 | 2004 | 9727 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2005 | 4687 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1451 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3327 | 0.040 |
Why?
|
| Ghana | 1 | 2018 | 286 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2015 | 2297 | 0.040 |
Why?
|
| Respiration | 2 | 2021 | 1653 | 0.040 |
Why?
|
| Hyperemia | 1 | 1998 | 225 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 4420 | 0.040 |
Why?
|
| Age Factors | 4 | 2020 | 18370 | 0.040 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 77 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 1999 | 367 | 0.040 |
Why?
|
| Periodicals as Topic | 2 | 2004 | 1432 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 6993 | 0.040 |
Why?
|
| Hypertrophy | 1 | 1998 | 569 | 0.040 |
Why?
|
| London | 1 | 1996 | 233 | 0.040 |
Why?
|
| Immunization | 1 | 2001 | 1256 | 0.040 |
Why?
|
| Animals | 12 | 2018 | 168757 | 0.030 |
Why?
|
| Incidence | 3 | 2015 | 20947 | 0.030 |
Why?
|
| Age Distribution | 2 | 2015 | 2902 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1997 | 253 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10397 | 0.030 |
Why?
|
| Immunization Programs | 1 | 1999 | 260 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 495 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4567 | 0.030 |
Why?
|
| Aortic Valve | 1 | 1986 | 1922 | 0.030 |
Why?
|
| Epoetin Alfa | 1 | 2016 | 83 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 2001 | 807 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 147 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 1997 | 165 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1997 | 406 | 0.030 |
Why?
|
| Rwanda | 1 | 2018 | 703 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3200 | 0.030 |
Why?
|
| Child Abuse | 1 | 2004 | 1030 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1995 | 23 | 0.030 |
Why?
|
| Taurine | 1 | 1996 | 94 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 459 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 150 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 1994 | 337 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2015 | 23338 | 0.030 |
Why?
|
| Health Surveys | 2 | 2013 | 4037 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 1995 | 88 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1999 | 1869 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 414 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 1681 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2022 | 5985 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 1996 | 207 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 449 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1997 | 292 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1998 | 1185 | 0.030 |
Why?
|
| Linear Models | 1 | 2005 | 5952 | 0.030 |
Why?
|
| Respiratory System | 1 | 1998 | 557 | 0.030 |
Why?
|
| Depersonalization | 1 | 2014 | 39 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1996 | 325 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 528 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2020 | 1133 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1801 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1997 | 440 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 1005 | 0.030 |
Why?
|
| Treatment Failure | 2 | 1999 | 2618 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2014 | 63 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2013 | 3528 | 0.030 |
Why?
|
| Home Care Services | 1 | 2010 | 606 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 1996 | 226 | 0.030 |
Why?
|
| Cephalometry | 1 | 2015 | 382 | 0.030 |
Why?
|
| Sleep Stages | 1 | 2017 | 686 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2014 | 183 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 231 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1616 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1999 | 721 | 0.030 |
Why?
|
| Glucose | 2 | 1998 | 4397 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 331 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 2 | 1999 | 547 | 0.030 |
Why?
|
| Esophageal Atresia | 1 | 1996 | 201 | 0.030 |
Why?
|
| Benzamides | 1 | 1998 | 1379 | 0.030 |
Why?
|
| Symporters | 1 | 2016 | 362 | 0.030 |
Why?
|
| Achievement | 1 | 2014 | 291 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 536 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 85 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 681 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1992 | 198 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 972 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1018 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1572 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 560 | 0.030 |
Why?
|
| Organizational Policy | 1 | 2014 | 429 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1456 | 0.030 |
Why?
|
| Kainic Acid | 1 | 1991 | 199 | 0.020 |
Why?
|
| Synapses | 1 | 2001 | 1728 | 0.020 |
Why?
|
| Stomach | 1 | 1996 | 697 | 0.020 |
Why?
|
| Potassium | 1 | 1996 | 1336 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2020 | 2052 | 0.020 |
Why?
|
| Decompression, Surgical | 2 | 2008 | 594 | 0.020 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 1991 | 56 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1743 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2001 | 10252 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Brain Mapping | 2 | 2005 | 6669 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12354 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3218 | 0.020 |
Why?
|
| Terminal Care | 1 | 2011 | 1694 | 0.020 |
Why?
|
| Family Health | 1 | 1994 | 1282 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 901 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 5137 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 782 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1995 | 975 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1677 | 0.020 |
Why?
|
| Partial Pressure | 2 | 1999 | 254 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2008 | 44 | 0.020 |
Why?
|
| Goals | 1 | 2013 | 706 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3798 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2624 | 0.020 |
Why?
|
| HIV Infections | 1 | 1994 | 16718 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 176 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 9849 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1249 | 0.020 |
Why?
|
| Food Additives | 1 | 1986 | 19 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10180 | 0.020 |
Why?
|
| Comorbidity | 2 | 2015 | 10388 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 520 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 151 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2002 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2014 | 2682 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2006 | 5788 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1986 | 174 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 156 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2005 | 80 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2400 | 0.020 |
Why?
|
| Orbit | 1 | 2008 | 426 | 0.020 |
Why?
|
| Potassium Deficiency | 1 | 2004 | 10 | 0.020 |
Why?
|
| APACHE | 1 | 2004 | 277 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2017 | 6196 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 86 | 0.010 |
Why?
|
| Periodicity | 1 | 2005 | 363 | 0.010 |
Why?
|
| Nutrition Therapy | 1 | 2005 | 96 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2010 | 956 | 0.010 |
Why?
|
| Hypophosphatemia | 1 | 2004 | 85 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2775 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2004 | 224 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2004 | 211 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 197 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 25043 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 2657 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3336 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 249 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2459 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2661 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 167 | 0.010 |
Why?
|
| National Health Programs | 1 | 2006 | 445 | 0.010 |
Why?
|
| Vaccination | 1 | 1994 | 3278 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 850 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2005 | 257 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1995 | 813 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 6103 | 0.010 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 257 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 793 | 0.010 |
Why?
|
| Cebidae | 1 | 1981 | 21 | 0.010 |
Why?
|
| Muscle Hypertonia | 1 | 1981 | 14 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2291 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7181 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2006 | 1063 | 0.010 |
Why?
|
| Coronavirus | 1 | 2003 | 158 | 0.010 |
Why?
|
| Saimiri | 1 | 1981 | 330 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1967 | 2290 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
| Craniotomy | 1 | 2005 | 729 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 786 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18029 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 819 | 0.010 |
Why?
|
| Seasons | 1 | 2005 | 1493 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2004 | 792 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1157 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8949 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 986 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 3537 | 0.010 |
Why?
|
| Violence | 1 | 2004 | 909 | 0.010 |
Why?
|
| Alkalosis | 1 | 1997 | 54 | 0.010 |
Why?
|
| Walking | 1 | 2005 | 1180 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1999 | 221 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 1486 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1092 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3282 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 1821 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1359 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 1614 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2004 | 1838 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1997 | 365 | 0.010 |
Why?
|
| Leucine | 1 | 1997 | 561 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1995 | 36 | 0.010 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 70 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1995 | 40 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4217 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7785 | 0.010 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1999 | 341 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1994 | 16 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1995 | 155 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1850 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1996 | 233 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 671 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1986 | 3821 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1981 | 986 | 0.010 |
Why?
|
| Biopsy | 2 | 1996 | 6756 | 0.010 |
Why?
|
| Echocardiography | 1 | 1986 | 5102 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1996 | 925 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3768 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1997 | 530 | 0.010 |
Why?
|
| Heart Failure | 1 | 1997 | 10900 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3271 | 0.010 |
Why?
|
| Propidium | 1 | 1991 | 41 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2376 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1994 | 256 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1320 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 481 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1996 | 399 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1107 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 1350 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 3749 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1991 | 424 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8642 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 1470 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 605 | 0.010 |
Why?
|
| Glycolysis | 1 | 1994 | 827 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1995 | 560 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1577 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 847 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1986 | 4584 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 751 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2418 | 0.000 |
Why?
|
| Middle Aged | 4 | 2014 | 213383 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3584 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 5319 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1100 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1986 | 15 | 0.000 |
Why?
|
| Sodium Glutamate | 1 | 1986 | 27 | 0.000 |
Why?
|
| Sensation | 1 | 1967 | 336 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1986 | 211 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4669 | 0.000 |
Why?
|
| Mouth | 1 | 1986 | 374 | 0.000 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1986 | 337 | 0.000 |
Why?
|
| Aged | 3 | 2004 | 163280 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15076 | 0.000 |
Why?
|
| Extremities | 1 | 1967 | 865 | 0.000 |
Why?
|
| Cerebral Decortication | 1 | 1981 | 11 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13695 | 0.000 |
Why?
|
| Movement | 1 | 1967 | 1471 | 0.000 |
Why?
|
| Face | 1 | 1986 | 994 | 0.000 |
Why?
|
| Food Hypersensitivity | 1 | 1986 | 622 | 0.000 |
Why?
|
| Meningioma | 1 | 1967 | 1209 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11483 | 0.000 |
Why?
|
| Electromyography | 1 | 1981 | 1379 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 57776 | 0.000 |
Why?
|